Luminary Therapeutics, Inc

Luminary Therapeutics, Inc

Biotechnology

Minneapolis, MN 859 followers

Overcoming Antigen Escape

About us

Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We have multiple solid tumor targets under development with a proprietary signaling method to ensure T-Cell persistence. Additionally, our Ligand BAFF CAR for hematologic cancers is designed with 3 antigen receptors specifically designed to overcome antigen escape. For more information visit www.luminarytx.com

Website
http://www.luminarytx.com
Industry
Biotechnology
Company size
2-10 employees
Headquarters
Minneapolis, MN
Type
Privately Held
Founded
2019

Locations

  • Primary

    1621 E Hennepin Ave

    Suite 290

    Minneapolis, MN 55414, US

    Get directions

Employees at Luminary Therapeutics, Inc

Updates

Similar pages

Browse jobs

Funding

Luminary Therapeutics, Inc 3 total rounds

Last Round

Pre seed

US$ 375.0K

See more info on crunchbase